Acquisition Announced
MiMedx Group acquisition of Sanara MedTech
US$350m enterprise value
Announced 29 Jul 2026 · NASDAQ: SMTI · US$35.00 cash and scrip per share · 46% premium
Advisers
Sanara MedTech
Target
- Financial adviser
- Legal adviser
- Fairness opinion
- Target
- Sanara MedTech
- Acquirer
- MiMedx Group
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Medtech
In the league tables
Similar deals
- Zimmer Biomet acquisition of Alafair Biosciences Aug 2026 · US$375m · Medtech
- iRhythm Holdings acquisition of VitalConnect Aug 2026 · US$288m · Medtech
- iRhythm Holdings acquisition of Vital Connect Aug 2026 · US$288m · Medtech
- Olympus acquisition of BioProtect May 2026 · US$270m · Medtech
- Smith+Nephew acquisition of Integrity Orthopaedics Jan 2026 · US$225m · Medtech
Sources
- 29 Jul 2026 Press release (EX-99.1, exhibit), MIMEDX to Acquire Sanara MedTech sec.gov
- 29 Jul 2026 Press release (EX-99.1, exhibit), to Acquire Sanara MedTech sec.gov
- 4 Sep 2026 Definitive merger proxy statement (DEFM14A), Sanara MedTech Inc. sec.gov

